Skip to main content

Table 1 Characteristics of people with epilepsy reported by the CAAE board members during the survey

From: Management of people with epilepsy during the COVID-19 pandemic: a national survey among epileptologists in China

Variates 

All

COVID-19 epidemic severity areas

 

Low-risk area

Moderate-risk area

High-risk area

P value

Number of surveyed responders, n

130

38

89

3

 

Average number of patients with consultation reported per responder, median (range)

155 (6, 1 400)

115 (18, 1 400)

179 (6, 1 210)

200 (150, 766)

 

Telephone- or internet-based consultationa, n (%)

81 (32.3)

93 (38.8)

67 (26.9)

329 (88.4)

< 0.001

Patients with regular case reviewa, n (%)

172 (68.6)

159 (66.5)

171 (68.2)

349 (93.9)

< 0.001

Patients with increased episodes of seizuresb, n (%)

26 (15.4)

26 (16.3)

25 (14.9)

62 (17.7)

0.006

Patients with status epilepticusb, n (%)

2 (0.9)

1 (0.8)

2 (1.0)

3 (0.9)

0.184

Patients with aggravation of psychological disordersb, n (%)

32 (18.8)

42 (26.2)

26 (15.1)

106 (30.2)

< 0.001

Patients who did not come for regular case review albeit they shouldc, n (%)

460 (73.3)

724 (82.0)

345 (67.6)

527 (60.2)

< 0.001

Patients who were unable to obtain ASMsa, n (%)

88 (35.0)

94 (39.4)

78 (31.1)

287 (77.2)

< 0.001

  1. ASMs antiseizure medications
  2. aAmong all the patients with consultation; bAmong patients with regular case review; cAmong all patients who should come for regular case review; n (%), the average number of patients reported per responder (%)